This inventor holds 1 USPTO granted patent and 1 published patent application, plus 2 CIPO patents and 1 EPO patent. Top assignee: University of Toronto. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Mulu Geletu-Heye: Innovator in STAT5 Inhibition
Introduction
Mulu Geletu-Heye is a prominent inventor based in Mississauga, Canada. She has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit specific biological pathways.
Latest Patents
Mulu holds a patent for sulfonamide compounds and their use as STAT5 inhibitors. This patent describes compounds that are designed to inhibit the STAT5 protein, which plays a crucial role in various cellular processes. The innovative compounds outlined in her patent have the potential to impact therapeutic strategies for diseases associated with STAT5 activity.
Career Highlights
Mulu Geletu-Heye is affiliated with the University of Toronto, where she engages in cutting-edge research. Her work focuses on the intersection of chemistry and biology, contributing to advancements in drug development and therapeutic applications.
Collaborations
Mulu has collaborated with notable colleagues, including Patrick Thomas Gunning and Abbarna A Cumaraswamy. These partnerships enhance her research efforts and foster innovation in her field.
Conclusion
Mulu Geletu-Heye is a trailblazer in the development of STAT5 inhibitors, with her patent representing a significant advancement in biochemistry. Her work at the University of Toronto and collaborations with esteemed colleagues further underscore her impact in the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile